Insilico Medicine showcases 10 years of AI success in drug discovery
GEN - 01-Aug-2024AI could cut preclinical drug development time by half, but rigorous trials are crucial
Previously the Live Forever Club — same community, now with a sharper mission for life extension
The world's most widely read biotechnology publication
Genetic Engineering & Biotechnology News (GEN) has retained its position as the number one biotech publisher around the globe since its launch in 1981. GEN publishes a print edition 21 times a year and has additional exclusive editorial content online, like news and analysis as well as blogs, podcasts, webinars, polls, videos, and application notes. GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.
Visit website: https://www.genengnews.com/
genetic-engineering-&-biotechnology-news
Details last updated 10-Dec-2019
AI could cut preclinical drug development time by half, but rigorous trials are crucial